Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7904404
Reference Type
Journal Article
Title
Improved Tag-Assisted Liquid-Phase Peptide Synthesis: Application to the Synthesis of the Bradykinin Receptor Antagonist Icatibant Acetate
Author(s)
Okada, Y; Takasawa, R; Kubo, D; Iwanaga, N; Fujita, S; Suzuki, K; Suzuki, H; Kamiya, H; Chiba, K
Year
2019
Is Peer Reviewed?
1
Journal
Organic Process Research and Development
ISSN:
1083-6160
Publisher
American Chemical Society
Volume
23
Issue
11
Page Numbers
2576-2581
Language
English
DOI
10.1021/acs.oprd.9b00397
Web of Science Id
WOS:000497260800034
Abstract
A cost- A nd time-effective synthetic method is a prerequisite to producing therapeutic peptides on a commercial scale. Herein we demonstrate that a soluble-tag-assisted liquid-phase peptide synthesis (LPPS) using a hydrophobic benzyl alcohol as a support is applicable to the 100 g scale production of therapeutic peptides using the bradykinin receptor antagonist icatibant acetate as a model. The use of sacrificial propylamine to trap the activated amino acids enables one-pot sequential couplings and deprotections without detectable double hits. With the modified procedure, precipitations at every other step are sufficient for the overall process, significantly reducing the amount of MeCN required. The complete consumption of starting materials (<0.05% remaining) at each step can be confirmed by a facile in-process control using HPLC, realizing the preparation of icatibant acetate with high purity (>99%). © 2019 American Chemical Society.
Keywords
medium molecule; peptide; soluble tag; LPPS; icatibant acetate
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity